Among the total of 446 gastric cancer specimens, TGF-β overexpression was detected in 181 (40.6%), HIF-1α overexpression in 217 (48.7%), VEGF overexpression in 194 (43.5%), and pERK overexpression in 149 (34.3%). This evidence concerns the gene VEGFA and gastric cancer.